New Study Validates Signatera™ in Endometrial Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. SPY
3. OWL
4. AMZN
5. FLUT
6. AVGO
7. AAPL
8. GNK
9. PENG
10. BABA

Go back to New Study Validates Signatera™ in Endometrial Cancer
(NASDAQ: NTRA) Delayed: 274.39 --0 (-0%)
Previous Close $274.39    52 Week High $13.80 
Open $274.39    52 Week Low $6.52 
Day High $274.39    P/E N/A 
Day Low $274.39    EPS $0.00 
Volume 1,834